Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive

Contraception

Volumn 81, Issue 2, 2010, Pages 107-111

  Pantoja, Márcia ^a   Medeiros, Tatiane ^a   Baccarin, Maria Carolina ^a   Morais, Sirlei Siani ^a   Bahamondes, Luis ^a   dos Santos Fernandes, Arlete Maria ^a  

^a School of Medical Sciences   (Brazil)

Author keywords

contraception; Depot medroxyprogesterone acetate; Obesity; Weight

Indexed keywords

COPPER INTRAUTERINE DEVICE; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; OBESITY; ORAL CONTRACEPTION; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INTRAUTERINE DEVICES, COPPER; MEDROXYPROGESTERONE ACETATE; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 73349129038     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.07.008     Document Type: Article

References (21)

1. Bakry S., Merhi Z.O., Scalise T.J., Mahmoud M.S., Fadiel A., and Naftolin F. Depot-medroxyprogesterone acetate: an update. Arch Gynecol Obstet 278 (2008) 1-12
2. Kaunitz A.M. Long-acting contraceptive options. Int J Fertil Menopausal Stud 41 (1996) 69-76
3. Fotherby K., and Koetsawang S. Metabolism of injectable formulations of contraceptive steroids in obese and thin women. Contraception 26 (1982) 51-58
4. Haider S., and Darney P.D. Injectable contraception. Clin Obstet Gynecol 50 (2007) 898-906
5. ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 107 (2006) 1453-1472
6. Espey E., Steinhart J., Ogburn T., and Qualls C. Depo-Provera associated with weight gain in Navajo women. Contraception 62 (2000) 55-58
7. Pelkman C. Hormones and weight change. J Reprod Med 47 (2002) 791-794
8. Bahamondes L., Del Castillo S., Tabares G., Arce X.E., Perrotti M., and Petta C. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years. Contraception 64 (2001) 223-225
9. Taneepanichskul S., Reinprayoon D., and Khaosaad P. Comparative study of weight change between long-term DMPA and IUD acceptors - a clinical evaluation. Contraception 58 (1998) 149-151
10. Clark M.K., Dillon J.S., Sowers M., and Nichols S. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes 29 (2005) 1252-1258
11. Mangan S.A., Larsen P.G., and Hudson S. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 15 (2002) 79-82
12. Bonny A.E., Ziegler J., Harvey R., Debanne S.M., Secic M., and Cromer B.A. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 160 (2006) 40-45
13. World Health Organization, Medical eligibility criteria for contraceptive use. Update 2008, 4th ed. Available at: http://www.who.int/reproductive-health/publications/mec/mec_update_2008. pdf
14. Armitage P., and Berry G. Statistical methods in medical research. 2nd ed. (1985), Blackwell Scientific Publications, Oxford
15. Hair J.F., Anderson R.E., Tatham R.L., and Black W.C. Multivariate data analysis. 5th ed. (1998), Prentice-Hall, Saddle River, NJ
16. Said S., Omar K., Koetsawang S., et al. A multicentred phase III comparative trial of depo-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg. 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 34 (1986) 223-235
17. Fraser I.S., and Weisberg E. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Aust 1 1 Suppl (1981) 3-9
18. Amatayakul K., Sivasomboon B., and Thanangkul O. A study of the mechanism of weight gain in medroxyprogesterone acetate users. Contraception 22 (1980) 605-622
19. Westhoff C., Jain J.K., Milsom I., and Ray A. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception 75 (2007) 261-267
20. Hassan D.F., Petta C.A., Aldrighi J.M., Bahamondes L., and Perrotti M. Weight variation in a cohort of women using copper IUD for contraception. Contraception 68 (2003) 27-30
21. Blanco-Molina A., Trujillo-Santos J., Tirado R., Cañas I., Riera A., Valdés M., et al. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb Haemost 101 (2009) 478-482